ResearcherHarvard UniversityActive in the last 2 years
Cristina R. Ferrone
Matched on OpenAlex author ID A5111040636. Sources: OpenAlex.
Their work
- Papers
- 5 (first author 1, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 53
2018: 1 paper · 2019: none · 2020: none · 2021: none · 2022: none · 2023: 1 paper · 2024: 2 papers · 2025: 1 paper
Papers 5
- Best Practices for Delivering Neoadjuvant Therapy in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1001/jamasurg.2024.5191↗
- Interplay between B7-H3 and HLA class I in the clinical course of pancreatic ductal adenocarcinoma. Last author DOI 10.1016/j.canlet.2024.216713↗
- The Molecular Twin artificial-intelligence platform integrates multi-omic data to predict outcomes for pancreatic adenocarcinoma patients. Co-author DOI 10.1038/s43018-023-00697-7↗
- Engineered nanomedicines to overcome resistance of pancreatic cancer to immunotherapy. First author DOI 10.1016/j.drudis.2022.103434↗
- 212Pb-labeled B7-H3-targeting antibody for pancreatic cancer therapy in mouse models. Co-author DOI 10.1016/j.nucmedbio.2017.12.004↗
Closest collaborators
The 25 strongest of 53 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Soldano Ferrone · 3 shared papers, 2018–2024 · strength 0.52
- Paper Engineered nanomedicines to overcome resistance of pancreatic cancer to immunotherapy. DOI 10.1016/j.drudis.2022.103434↗
- Paper Interplay between B7-H3 and HLA class I in the clinical course of pancreatic ductal adenocarcinoma. DOI 10.1016/j.canlet.2024.216713↗
- Paper 212Pb-labeled B7-H3-targeting antibody for pancreatic cancer therapy in mouse models. DOI 10.1016/j.nucmedbio.2017.12.004↗
- Ahmed O. Elzoghby · 1 shared paper, 2023 · strength 0.26
- Mahmoud Lotfi Nasr · 1 shared paper, 2023 · strength 0.26
- Andrew Eugene Hendifar · 1 shared paper, 2024 · strength 0.18
- Dan Theodorescu · 1 shared paper, 2024 · strength 0.18
- Lei Zheng · 1 shared paper, 2024 · strength 0.18
- Arsen Osipov · 1 shared paper, 2024 · strength 0.18
- David Tsai Ting · 1 shared paper, 2024 · strength 0.17
- Yurie Sekigami · 1 shared paper, 2024 · strength 0.17
- Paul A. Moore · 1 shared paper, 2024 · strength 0.17
- Lei Cai · 1 shared paper, 2024 · strength 0.17
- Theodoros P. Michelakos · 1 shared paper, 2024 · strength 0.17
- Marco Ventin · 1 shared paper, 2024 · strength 0.17
- Giulia Cattaneo · 1 shared paper, 2024 · strength 0.17
- Xinhui Wang · 1 shared paper, 2024 · strength 0.17
- Vikram Deshpande · 1 shared paper, 2024 · strength 0.17
- Nabeel M. Bardeesy · 1 shared paper, 2024 · strength 0.17
- Davendra P. S. Sohal · 1 shared paper, 2025 · strength 0.15
- Andrew H. Ko · 1 shared paper, 2025 · strength 0.15
- Alok A. Khorana · 1 shared paper, 2025 · strength 0.15
- Matthew H. G. Katz · 1 shared paper, 2025 · strength 0.15
- Steve Walston · 1 shared paper, 2025 · strength 0.15
- P. A. Philip · 1 shared paper, 2025 · strength 0.15
- Melissa Ellen Hogg · 1 shared paper, 2025 · strength 0.15
- Matthew J. Arango · 1 shared paper, 2025 · strength 0.15
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.